TY  - JOUR
AU  - Scuteri, Damiana
AU  - Pagliaro, Martina
AU  - Mantia, Isabel
AU  - Contrada, Marianna
AU  - Pignolo, Loris
AU  - Tonin, Paolo
AU  - Nicotera, Pierluigi
AU  - Bagetta, Giacinto
AU  - Corasaniti, Maria Tiziana
TI  - Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial.
JO  - Frontiers in pharmacology
VL  - 15
SN  - 1663-9812
CY  - Lausanne
PB  - Frontiers Media
M1  - DZNE-2024-01043
SP  - 1417851
PY  - 2024
AB  - An estimated 57.4 million people live with dementia worldwide, with the social burden of the disease steadily growing. Despite the approval of lecanemab and ongoing trials, there is still a lack of effective and safe treatments for behavioral and psychological symptoms of dementia (BPSD), which affect 99
KW  - BRAINAID (Other)
KW  - NCT04321889 (Other)
KW  - NanoBEO (Other)
KW  - agitation (Other)
KW  - behavioural and psychological symptoms of dementia (Other)
KW  - dementia (Other)
KW  - pain (Other)
KW  - pilot clinical trial (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:39148533
C2  - pmc:PMC11325727
DO  - DOI:10.3389/fphar.2024.1417851
UR  - https://pub.dzne.de/record/271342
ER  -